A new process to produce human thrombin & fibrinogen to meet the demands of the civic & military trauma treatment markets for more effective human blood clotting proteins to control serious bleeding. It could be produced in injectable forms, as a dressing, as a sealant, etc. It is the ONLY product based on human stem cells. The resulting molecules are and react identical to what the human body produces; delivering a more effective product.